Biological Signatures of Asymptomatic Extra- and Intracranial Atherosclerosis
Open Access
- 1 October 2012
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Stroke
- Vol. 43 (10), 2712-2719
- https://doi.org/10.1161/strokeaha.112.661702
Abstract
Background and Purpose—Intracranial atherosclerotic disease (ICAD) remains a challenge for stroke primary and secondary prevention. Molecular pathways involved in the development of ICAD from its asymptomatic stages are largely unknown. In our population-based study, we aimed to compare the risk factor and biomarker profiles associated with intracranial and extracranial asymptomatic cerebral atherosclerosis. Methods—The Asymptomatic Intracranial Atherosclerosis (AsIA) study cohort includes a random sample population of 933 white subjects >50 years with a moderate to high vascular risk (based on REGICOR score) and without a history of stroke (64% males; mean age, 66 years). Carotid and intracranial atherosclerosis were screened by cervical and transcranial color-coded Duplex ultrasound, being moderate to severe stenoses confirmed by MR angiography. We registered clinical and anthropometric data and created a biobank with blood samples at baseline. A panel of biomarkers involved in atherothrombogenesis was determined: C-reactive protein, asymmetric-dimethylarginine, resistin, and plasminogen activator inhibitor-1. Insulin resistance was quantified by Homeostasis Model Assessment index. Results—After multinomial regression analyses, male sex, hypertension, smoking, and alcoholic habits were independent risk factors of isolated extracranial atherosclerotic disease. Diabetes and metabolic syndrome conferred a higher risk for ICAD than for extracranial atherosclerotic disease. Moreover, metabolic syndrome and insulin resistance were independent risk factors of moderate to severe ICAD but were not risk factors of moderate to severe extracranial atherosclerotic disease. Regarding biomarkers, asymmetric-dimethylarginine was independently associated with isolated ICAD and resistin with combined ICAD–extracranial atherosclerotic disease. Conclusions—Our findings show distinct clinical and biological profiles in subclinical ICAD and extracranial atherosclerotic disease. Insulin resistance emerged as an important molecular pathway involved in the development of ICAD from its asymptomatic stage.This publication has 33 references indexed in Scilit:
- High Levels of Apolipoprotein B/AI Ratio Are Associated With Intracranial Atherosclerotic StenosisStroke, 2011
- Stenting versus Aggressive Medical Therapy for Intracranial Arterial StenosisThe New England Journal of Medicine, 2011
- Global Variation in the Relative Burden of Stroke and Ischemic Heart DiseaseCirculation, 2011
- The population-based Barcelona-Asymptomatic Intracranial Atherosclerosis Study (ASIA): rationale and designBMC Neurology, 2011
- Harmonizing the Metabolic SyndromeCirculation, 2009
- Impact of metabolic syndrome on distribution of cervicocephalic atherosclerosis: Data from a diverse race-ethnic groupJournal of the Neurological Sciences, 2009
- Association of the Endogenous Nitric Oxide Synthase Inhibitor ADMA With Carotid Artery Intimal Media Thickness in the Framingham Heart Study Offspring CohortStroke, 2009
- Incidence and Risk Factors of Intracranial Atherosclerotic Stroke: The Northern Manhattan Stroke StudyCerebrovascular Diseases, 2009
- Progression of Symptomatic Intracranial Large Artery Atherosclerosis Is Associated With a Proinflammatory State and Impaired FibrinolysisStroke, 2008
- Validity of an adaptation of the Framingham cardiovascular risk function: the VERIFICA studyJournal of Epidemiology and Community Health, 2007